Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of INFLIXIMAB With TOFACITINIB in ASUC - CINTO Trial

NCT07297069 is registered in ClinicalTrials.gov with Asian Institute of Gastroenterology, India as lead sponsor.

NCT NCT07297069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07297069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of INFLIXIMAB With TOFACITINIB in ASUC - CINTO Trial
Lead sponsor
Asian Institute of Gastroenterology, India
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
December 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute severe ulcerative colitis